CROs offering Biomarker Assays with Radiopharmaceutical
8 published
8 published CROs match Biomarker Assays and Radiopharmaceutical.
Locations in this set include United States, United Kingdom, China, France, Israel, and Singapore.
Capabilities that show up most often in this set: Bioanalysis, Flow Cytometry Services, Immunology & Inflammation Services, In Vitro Pharmacology, and In Vivo Efficacy Models.
Matching companies
ACM Global LaboratoriesGlobal clinical trial central lab and bioanalytical services provider with 40+ years of experience supporting drug development across 65+ countries.
Champions OncologyLeading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services.
Crown BiosciencePreclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.
LabcorpLabcorp is a global life sciences and healthcare company providing diagnostic testing, drug development, nonclinical research, central laboratory services, and real-world data solutions to healthcare providers, health systems, and biopharma companies.
MedpaceFull-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
Oncodesign ServicesContract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Synexa Life SciencesBiomarker and bioanalytical CRO offering custom assay development, validation and clinical sample analysis by LC-MS/MS, MSD, flow cytometry and Olink proteomics. Labs in Manchester, Turku and Cape Town support work from discovery through regulatory submission.
Markdown mirror: /explore/biomarker-assays/radiopharmaceutical.md